• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Heart Test Laboratories Inc.

    12/11/23 8:30:12 AM ET
    $HSCS
    Industrial Specialties
    Health Care
    Get the next $HSCS alert in real time by email
    SC 13G 1 ea189735-13gmatthews_heart.htm SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. )*

     

     

    HEART TEST LABORATORIES, INC.

    (Name of Issuer)

     

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)

     

    42254E104

    (CUSIP Number)

     

    November 15, 2023

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)

     

    ☒ Rule 13d-1(c)

     

    ☐Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    SCHEDULE 13G

     

    CUSIP No. 42254E104

     

    Person 1

     

    (1)

    Names of reporting persons

     

    Matthews Holdings Southwest Inc.

    EIN 75-2321197

    (2)

    Check the appropriate box if a member of a group (see instructions)

     

    (a) ☐        (b) ☐

    (3)

    SEC use only

     

     

    (4)

    Citizenship or place of organization:

     

    Texas

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person

    with:

    (5)

    Sole voting power

     

    5,241,758(1)

    (6)

    Shared voting power

     

    0

    (7)

    Sole dispositive power

     

    5,241,758(1)

    (8)

    Shared dispositive power

     

    0

    (9)

    Aggregate amount beneficially owned by each reporting person

     

    5,241,758(1)

    (10)

    Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    ☐

    (11)

    Percent of class represented by amount in Row (9)

     

    8.1%(1)

    (12)

    Type of reporting person (see instructions)

     

    CO

     

    (1)John H. Matthews (the “Reporting Person”), as sole controlling shareholder of Matthews Holdings Southwest, Inc., has sole voting and dispositive power over all such shares. The Reporting Person’s ownership consists of (i) 3,972,549 shares of common stock, and (ii) 1,269,209 shares of common stock issuable upon exercise of certain warrants, MSW Warrants, or Pre-Funded Bridge Warrants.

     

    2

     

     

    Person 2

     

    (1)

    Names of reporting persons

     

    John H. Matthews

    (2)

    Check the appropriate box if a member of a group (see instructions)

     

    (a) ☐        (b) ☐

    (3)

    SEC use only

     

     

    (4)

    Citizenship or place of organization:

     

    United States

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person

    with:

    (5)

    Sole voting power

     

    5,241,758(1)

    (6)

    Shared voting power

     

    0

    (7)

    Sole dispositive power

     

    5,241,758(1)

    (8)

    Shared dispositive power

     

    0

    (9)

    Aggregate amount beneficially owned by each reporting person

     

    5,241,758(1)

    (10)

    Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    ☐

    (11)

    Percent of class represented by amount in Row (9)

     

    8.1%(1)

    (12)

    Type of reporting person (see instructions)

     

    IN

     

    3

     

     

    Item 1.

    (a) Name of Issuer:

     

    Heart Test Laboratories, Inc.

     

    (b) Address of Issuer’s Principal Executive Offices:

     

    550 Reserve St, Suite 360
    Southlake, Texas 76092

     

    Item 2.

    (a) Name of Person Filing

     

    Matthews Holdings Southwest Inc.

     

    (b) Address of principal business office or, if none, residence:

     

    320 W. Main St., Lewisville, TX 75057-3866

     

    (c) Citizenship:

     

    The Reporting Person is a Texas Corporation

     

    (d) Title of Class of Securities:

     

    Common Stock, par value $0.001 per share

     

    (e) CUSIP Number:

     

    42254E104

     

    Item 3.

    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    Not Applicable

     

    Item 4.

    Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a) Amount beneficially owned: 5,241,758

     

    (b) Percent of class: 8.1%

     

    (c) Number of shares as to which the person has:

     

    (i) Sole power to vote or to direct the vote: 5,241,758

     

    (ii) Shared power to vote or to direct the vote: 0

     

    (iii) Sole power to dispose or to direct the disposition of: 5,241,758

     

    (iv) Shared power to dispose or to direct the disposition of: 0

     

    4

     

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

     

    Not Applicable

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person.

     

    Not Applicable

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

     

    Not Applicable

     

    Item 8.

    Identification and Classification of Members of the Group.

     

    Not Applicable

     

    Item 9.

    Notice of Dissolution of Group.

     

    Not Applicable

     

    Item 10.

    Certification.

     

    Not Applicable

     

    5

     

     

    SCHEDULE 13G

     

    CUSIP No. 42254E104    

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

       
    Dated: December 11, 2023  
       
    /s/ John H. Matthews  
    John H. Matthews  

     

    Matthews Holdings Southwest Inc.

     

    By:  /s/ John H. Matthews   
      Name:  John H. Matthews  
      Title: Chief Executive Officer  

     

     

    6

     

    Get the next $HSCS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HSCS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HSCS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Officer Watson Danielle

    4 - HeartSciences Inc. (0001468492) (Issuer)

    7/9/26 9:30:02 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    Officer Simpson Andrew was granted 425,000 shares, increasing direct ownership by 571% to 499,382 units (SEC Form 4)

    4 - HeartSciences Inc. (0001468492) (Issuer)

    6/24/26 6:35:36 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Wells David R.

    4 - HeartSciences Inc. (0001468492) (Issuer)

    1/12/26 8:03:32 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    $HSCS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    These Emerging Companies Are Racing Toward Major Catalysts

    DENVER, June 23, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- Today’s common theme is scale. Whether through regulatory advancement, access to new capital, expanding commercial opportunities, or technological innovation, companies that successfully execute during periods of rapid change often find themselves at important inflection points. NeOnc Technologies Approaches Major Clinical Catalyst NeOnc Technologies (NASDAQ:NTHI) has emerged as a company attracting attention within the neuro-oncology sector after announcing that the Department of Health–Abu Dhabi granted Investigational New Drug authorization for its NEO100 program. The approval covers multiple protocols spanning adult Pha

    6/23/26 11:11:05 AM ET
    $NTHI
    $BOLD
    $BLZE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

    Combined company expected to operate under the Fortitude brand and to trade on Nasdaq under the ticker symbol "TUDE"; transaction expected to close in H2 2026 Upon completion of the transaction, Fortitude believes it will be the first publicly traded venture mining platform with a track record of identifying high-conviction, early-stage Proof-of-Work opportunities Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences"), an AI-powered medical technology company, today announced that they have entered into a definitive merger agreement to combine in an all-stock transacti

    6/23/26 7:30:00 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents

    Southlake, TX, June 11, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or "EKG") through the integration of artificial intelligence ("AI"), today announced the grant by the European Patent Office (EPO) of European Patent No. EP4252651, titled "Electrocardiogram-Based Assessment of Diastolic Function." The patent covers machine-learning models and methods for computing quantitative estimates of echocardiogram parameters indicative of diastolic function using ECG data and patient demographic parameters. "Securing European patent protectio

    6/11/26 8:30:00 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    $HSCS
    SEC Filings

    View All

    SEC Form DEFA14A filed by HeartSciences Inc.

    DEFA14A - HeartSciences Inc. (0001468492) (Filer)

    7/10/26 5:02:28 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    HeartSciences Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits

    8-K - HeartSciences Inc. (0001468492) (Filer)

    7/10/26 5:00:18 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form DEFA14A filed by HeartSciences Inc.

    DEFA14A - HeartSciences Inc. (0001468492) (Filer)

    6/26/26 5:23:22 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    $HSCS
    Leadership Updates

    Live Leadership Updates

    View All

    HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

    Southlake, TX, May 07, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Dr. Girish Nadkarni, MD, Dr. Joshua Lampert, MD, and Dr. Akhil Vaid, MBBS, to its Scientific Advisory Board. These appointments underscore HeartSciences' commitment to advancing and transforming data-driven AI-ECG technology. "We are honored to welcome Dr. Girish Nadkarni, Dr. Joshua Lampert, and Dr. Akhil Vaid to our Scientific Advisory Board," said Andrew Simpson, CEO of HeartScien

    5/7/25 9:00:00 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    HeartSciences Adds Key Advisor to its Scientific Advisory Board

    Southlake, TX, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Dr. Partho P. Sengupta, MD, MBBS, FACC, to its Scientific Advisory Board. "Dr. Sengupta has been an author on multiple peer reviewed AI-ECG publications using the Company's technology and we are delighted to have someone of his caliber join our growing Scientific Advisory Board," said Andrew Simpson, CEO of HeartSciences. "Dr. Sengupta has

    2/26/24 9:00:00 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    HeartSciences Expands its Scientific Advisory Board

    Southlake, TX, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Jordan B. Strom M.D., M.Sc., to its Scientific Advisory Board. "Dr. Strom has been assisting us in recent interactions with the FDA and we are delighted to welcome him to our Scientific Advisory Board as we prepare for FDA submission of our MyoVista device and cloud platform, in addition to algorithms licensed from the Icahn School of Medi

    2/12/24 9:00:00 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    $HSCS
    Financials

    Live finance-specific insights

    View All

    Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

    Combined company expected to operate under the Fortitude brand and to trade on Nasdaq under the ticker symbol "TUDE"; transaction expected to close in H2 2026 Upon completion of the transaction, Fortitude believes it will be the first publicly traded venture mining platform with a track record of identifying high-conviction, early-stage Proof-of-Work opportunities Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences"), an AI-powered medical technology company, today announced that they have entered into a definitive merger agreement to combine in an all-stock transacti

    6/23/26 7:30:00 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

    Southlake, TX, Sept. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart disease, today announced its financial results for the first quarter of fiscal 2026 ended July 31, 2025 ("FQ1 2026") and provided a business update highlighting continued progress. First Quarter and Recent Highlights HeartSciences has made substantial progress during FQ1 2026 which saw the Company achieve an FDA Breakthrough Device Designation and successfully launched MyoVista Insights. MyoVista Insights™ Software Platform HeartScie

    9/11/25 4:15:00 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

    Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart disease, today announced its financial results for the fiscal year ended April 30, 2025, and provided a business update highlighting significant strategic progress. Fiscal 2025 and Business Highlights HeartSciences made substantial advancements during fiscal year 2025, marking a pivotal shift in its strategy to enhance the clinical value of ECGs through AI and cloud-based technologies that can be deployed across diverse healthcare settin

    7/24/25 4:15:00 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    $HSCS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Heart Test Laboratories Inc.

    SC 13G - Heart Test Laboratories, Inc. (0001468492) (Subject)

    12/11/23 8:30:12 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Heart Test Laboratories Inc.

    SC 13G - Heart Test Laboratories, Inc. (0001468492) (Subject)

    11/27/23 4:02:41 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form SC 13D filed by Heart Test Laboratories Inc.

    SC 13D - Heart Test Laboratories, Inc. (0001468492) (Subject)

    6/14/23 5:06:17 PM ET
    $HSCS
    Industrial Specialties
    Health Care